Dear Dr Park,
Re: "TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model"
We are delighted to let you know that the above submission, which you co-authored, has been accepted for publication in Scientific Reports.